tiprankstipranks
Trending News
More News >
Uscom Limited (AU:UCM)
ASX:UCM
Australian Market

Uscom Limited (UCM) Price & Analysis

Compare
0 Followers

UCM Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

33.65%66.35%
33.65% Insiders
Mutual Funds
― Other Institutional Investors
66.35% Public Companies and
Individual Investors

UCM FAQ

What was Uscom Limited’s price range in the past 12 months?
Uscom Limited lowest share price was AU$0.01 and its highest was AU$0.06 in the past 12 months.
    What is Uscom Limited’s market cap?
    Uscom Limited’s market cap is AU$5.01M.
      When is Uscom Limited’s upcoming earnings report date?
      Uscom Limited’s upcoming earnings report date is Aug 14, 2025 which is in 53 days.
        How were Uscom Limited’s earnings last quarter?
        Uscom Limited released its earnings results on Feb 26, 2025. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.
          Is Uscom Limited overvalued?
          According to Wall Street analysts Uscom Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Uscom Limited pay dividends?
            Uscom Limited does not currently pay dividends.
            What is Uscom Limited’s EPS estimate?
            Uscom Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Uscom Limited have?
            Uscom Limited has 250,477,000 shares outstanding.
              What happened to Uscom Limited’s price movement after its last earnings report?
              Uscom Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Uscom Limited?
                Currently, no hedge funds are holding shares in AU:UCM

                Uscom Limited Stock Smart Score

                4
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                11.11%
                12-Months-Change

                Fundamentals

                Return on Equity
                -117.20%
                Trailing 12-Months
                Asset Growth
                -22.96%
                Trailing 12-Months

                Company Description

                Uscom Limited

                Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company also provides the SpiroSonic AIR, a digital multipath ultrasonic spirometer with a viral disinfection system for the elimination of COVID and tuberculosis; and respiratory devices. It serves hospitals and other medical care locations through a network of distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia.
                Similar Stocks
                Company
                Price & Change
                Follow
                HeraMED Ltd.
                Atomo Diagnostics Ltd.
                Adherium Ltd.
                InhaleRx Limited
                Control Bionics Ltd.
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis